Agios Pharmaceuticals, Inc. (AGIO) NASDAQ

39.19

-0.04(-0.10%)

Updated at July 15 04:00PM

Currency In USD

Agios Pharmaceuticals, Inc.

Address

88 Sidney Street

Cambridge, MA 02139-4169

United States of America

Phone

617 649 8600

Sector

Healthcare

Industry

Biotechnology

Employees

486

First IPO Date

July 24, 2013

Key Executives

NameTitlePayYear Born
Mr. Brian M. Goff M.B.A.Chief Executive Officer & Director1.55M1969
Dr. Lewis clayton Cantley Ph.D.Co-Founder50,0001949
Ms. Cecilia JonesChief Financial Officer802,5741975
Mr. James William BurnsCorporate Secretary & Chief Legal Officer815,7321978
Ms. Tsveta MilanovaChief Commercial Officer836,6431977
Dr. Sarah Gheuens M.D., Ph.D.Chief Medical Officer and Head of Research & Development927,5721980
Dr. Shin-San Su Ph.D.Co-Founder01956
Dr. Craig B. Thompson M.D.Co-Founder01953
Mr. T. J. WashburnVice President, Controller & Principal Accounting Officer01982
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D.Co-Founder01946

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.